» Articles » PMID: 31588840

Iatrogenic Blood Loss in Extreme Preterm Infants Due to Frequent Laboratory Tests and Procedures

Overview
Publisher Informa Healthcare
Date 2019 Oct 8
PMID 31588840
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the cumulative amount of iatrogenic blood loss in extreme preterm infants during the first month of life.

Study Design: We performed an observational cohort study in 20 extreme preterm infants (gestational age <28 weeks). We recorded the amount of blood drawn for laboratory testing during the first 4 weeks of life, the number of punctures for phlebotomy and intravenous access and the amount of blood loss associated with these procedures. We compared the cumulative blood loss to the estimated total blood volume (85 ml/kg body weight) and to the total volume of red blood cell (RBC) transfusions administered during the same study period.

Results: The median cumulative iatrogenic blood loss was 24.2 ml/kg (interquartile range (IQR) 15.8-30.3 ml/kg) per patient, which equals a median of 28.5% (IQR 18.6-35.6%) of the total blood volume. Blood loss was higher in the most extreme preterm infants (30.2 ml/kg at 24 weeks versus 15.9 ml/kg at 27 weeks). The median number of punctures per infant was 47 (IQR 26-56) during the first 4 weeks of life. The median volume of RBC transfusions administered during the study period was 30 ml/kg, slightly more than the cumulative blood loss (24.2 ml/kg).

Conclusions: Extreme preterm infants lose almost one-third of their total blood volume in the first month of life as a result of blood loss due to multiple blood draws for laboratory investigations, and procedures.

Citing Articles

[Clinical practice guidelines for the diagnosis and treatment of anemia of prematurity (2025)].

Zhongguo Dang Dai Er Ke Za Zhi. 2025; 27(1):1-17.

PMID: 39825646 PMC: 11750247. DOI: 10.7499/j.issn.1008-8830.2407094.


Coagulation assay results at birth in preterm infants: A cohort study highlighting the relevance of local reference values for interpretation.

Houben N, Fustolo-Gunnink S, Caram-Deelder C, Visser R, Bosma M, Fijnvandraat K Vox Sang. 2024; 120(1):55-62.

PMID: 39557418 PMC: 11753824. DOI: 10.1111/vox.13766.


Red Blood Cell Transfusion in European Neonatal Intensive Care Units, 2022 to 2023.

Houben N, Fustolo-Gunnink S, Fijnvandraat K, Caram-Deelder C, Aguar Carrascosa M, Beuchee A JAMA Netw Open. 2024; 7(9):e2434077.

PMID: 39298172 PMC: 11413711. DOI: 10.1001/jamanetworkopen.2024.34077.


Red Blood Cell Transfusion for Incidence of Retinopathy of Prematurity: Prospective Multicenter Cohort Study.

Wang X, Rao R, Li H, Lei X, Dong W JMIR Pediatr Parent. 2024; 7:e60330.

PMID: 39297519 PMC: 11425406. DOI: 10.2196/60330.


Proteomics-Based Mapping of Bronchopulmonary Dysplasia-Associated Changes in Noninvasively Accessible Oral Secretions.

Ahmed S, Odumade O, van Zalm P, Fatou B, Hansen R, Martin C J Pediatr. 2023; 270:113774.

PMID: 37839510 PMC: 11014893. DOI: 10.1016/j.jpeds.2023.113774.